Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1978 Sep;27(3):475–482. doi: 10.1128/jvi.27.3.475-482.1978

Effects of adenine arabinoside on lymphocytes infected with Epstein-Barr virus.

W C Benz, P J Siegel, J Baer
PMCID: PMC525834  PMID: 212577

Abstract

Low concentrations of adenine arabinoside inhibited growth of two Epstein-Barr virus producer cell lines in culture, while not significantly affecting a nonproducer cell line and a B-cell-negative line. These observations were extended to include freshly infected cells. Mitogen-stimulated human umbilical cord blood lymphocytes were unaffected by the drug at concentration levels that inhibited [3H]thymidine incorporation into the DNA of Epstein-Barr virus-stimulated cells. DNA synthesis in Epstein-Barr virus-superinfected Raji cells was also adversely affected by adenine arabinoside. However, these same low concentrations of adenine arabinoside in the triphosphate form produced less effect on DNA synthesis in nuclear systems and DNA polymerase assays than on growth or DNA synthesis in whole cells. Therefore the effects reported here of low concentrations of the drug on whole cells may be only in part related to DNA polymerase inhibition. The work reported here suggests that adenine arabinoside has multiple sites of action in infected cells.

Full text

PDF
475

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel R., Jr, Kaufman H. E., Sugar J. Intravenous adenine arabinoside against herpes simplex keratouveitis in humans. Am J Ophthalmol. 1975 Apr;79(4):659–664. doi: 10.1016/0002-9394(75)90807-7. [DOI] [PubMed] [Google Scholar]
  2. BRINK J. J., LEPAGE G. A. 9-BETA-D-ARABINOFURANOSYLADENINE AS AN INHIBITOR OF METABOLISM IN NORMAL AND NEOPLASTIC CELLS. Can J Biochem. 1965 Jan;43:1–15. doi: 10.1139/o65-001. [DOI] [PubMed] [Google Scholar]
  3. Benz W. C., Strominger J. L. Viral and cellular DNA synthesis in nuclei from human lymphocytes transformed by Epstein-Barr virus. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2413–2417. doi: 10.1073/pnas.72.6.2413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bryson Y., Connor J. D., Sweetman L., Carey S., Stuckey M. A., Buchanan R. Determination of plaque inhibitory activity of adenine arabinoside (9-beta-D-arabinofuranosyladenine) for herpesviruses using an adenosine deaminase inhibitor. Antimicrob Agents Chemother. 1974 Jul;6(1):98–101. doi: 10.1128/aac.6.1.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Böyum A. Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents. Scand J Clin Lab Invest Suppl. 1968;97:31–50. [PubMed] [Google Scholar]
  6. Ch'ien L. T., Cannon N. J., Charamella L. J., Dismukes W. E., Whitley R. J., Buchanan R. A., Alford C. A., Jr Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. J Infect Dis. 1973 Nov;128(5):658–663. doi: 10.1093/infdis/128.5.658. [DOI] [PubMed] [Google Scholar]
  7. Ch'ien L. T., Cannon N. J., Whitley R. J., Diethelm A. G., Dismukes W. E., Scott C. W., Buchanan R. A., Alford C. A., Jr Effect of adenine arabinoside on cytomegalovirus infections. J Infect Dis. 1974 Jul;130(1):32–39. doi: 10.1093/infdis/130.1.32. [DOI] [PubMed] [Google Scholar]
  8. Ch'ien L. T., Whitley R. J., Nahmias A. J., Lewin E. B., Linnemann C. C., Jr, Frenkel L. D., Bellanti J. A., Buchanan R. A., Alford D. A., Jr Antiviral chemotherapy and neonatal herpes simplex virus infecition: a pilot study--experience with adenine arabinoside (ARA-A). Pediatrics. 1975 May;55(5):678–685. [PubMed] [Google Scholar]
  9. Coker-Vann M., Dolin R. Effect of adenine arabinoside on Epstein-Barr virus in vitro. J Infect Dis. 1977 Mar;135(3):447–453. doi: 10.1093/infdis/135.3.447. [DOI] [PubMed] [Google Scholar]
  10. Freeman G., Kuehn A., Sultanian I. Tumorigenic virus and cell responses to biologically active compounds. II. Pharmacologic specificity in cell-virus relationships. Ann N Y Acad Sci. 1965 Jul 30;130(1):330–342. doi: 10.1111/j.1749-6632.1965.tb12567.x. [DOI] [PubMed] [Google Scholar]
  11. Furth J. J., Cohen S. S. Inhibition of mammalian DNA polymerase by the 5'-triphosphate of 1-beta-d-arabinofuranosylcytosine and the 5'-triphosphate of 9-beta-d-arabinofuranoxyladenine. Cancer Res. 1968 Oct;28(10):2061–2067. [PubMed] [Google Scholar]
  12. Gerber P., Hoyer B. H. Induction of cellular DNA synthesis in human leukocytes by Epstein-Barr virus. Nature. 1971 May 7;231(5297):46–47. doi: 10.1038/231046a0. [DOI] [PubMed] [Google Scholar]
  13. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hinuma Y., Grace J. T., Jr Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long-term cultures. Proc Soc Exp Biol Med. 1967 Jan;124(1):107–111. doi: 10.3181/00379727-124-31677. [DOI] [PubMed] [Google Scholar]
  15. Klein G., Lindahl T., Jondal M., Leibold W., Menézes J., Nilsson K., Sundström C. Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A. 1974 Aug;71(8):3283–3286. doi: 10.1073/pnas.71.8.3283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Miller G., Shope T., Lisco H., Stitt D., Lipman M. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc Natl Acad Sci U S A. 1972 Feb;69(2):383–387. doi: 10.1073/pnas.69.2.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moore E. C., Cohen S. S. Effects of arabinonucleotides on ribonucleotide reduction by an enzyme system from rat tumor. J Biol Chem. 1967 May 10;242(9):2116–2118. [PubMed] [Google Scholar]
  18. Müller W. E., Maidhof A., Zahn R. K., Shannon W. M. Effect of 9-beta-D-arabinofuranosyladenine on DNA synthesis in vivo. Cancer Res. 1977 Jul;37(7 Pt 1):2282–2290. [PubMed] [Google Scholar]
  19. Müller W. E., Rohde H. J., Beyer R., Maidhof A., Lachmann M., Taschner H., Kahn R. K. Mode of action of 9-beta-D-arabinofuranosyladenine on the synthesis of DNA, RNA, and protein in vivo and in vitro. Cancer Res. 1975 Aug;35(8):2160–2168. [PubMed] [Google Scholar]
  20. Müller W. E., Zahn R. K., Bittlingmaier K., Falke D. Inhibition of herpesvirus DNA synthesis by 9-beta-D-arabinofuranosyladenine in cellular and cell-free systems. Ann N Y Acad Sci. 1977 Mar 4;284:34–48. doi: 10.1111/j.1749-6632.1977.tb21935.x. [DOI] [PubMed] [Google Scholar]
  21. NICHOLS W. W. IN VITRO CHROMOSOME BREAKAGE INDUCED BY ARABINOSYLADENINE IN HUMAN LEUKOCYTES. Cancer Res. 1964 Sep;24:1502–1505. [PubMed] [Google Scholar]
  22. Nonoyama M., Pagano J. S. Replication of viral deoxyribonucleic acid and breakdown of cellular deoxyribonucleic acid in Epstein-Barr virus infection. J Virol. 1972 Apr;9(4):714–716. doi: 10.1128/jvi.9.4.714-716.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nyormoi O., Thorley-Lawson D. A., Elkington J., Strominger J. L. Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production. Proc Natl Acad Sci U S A. 1976 May;73(5):1745–1748. doi: 10.1073/pnas.73.5.1745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. PRIVATDEGARILHE M., DE RUDDER J. EFFET DE DEUX NUCL'EOSIDES DE L'ARABINOSE SUR LA MULTIPLICATION DES VIRUS DE L'HERP'ES ET DE LA VACCINE EN CULTURE CELLULAIRE. C R Hebd Seances Acad Sci. 1964 Oct 19;259:2725–2728. [PubMed] [Google Scholar]
  25. PULVERTAFT J. V. CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA). Lancet. 1964 Feb 1;1(7327):238–240. doi: 10.1016/s0140-6736(64)92345-1. [DOI] [PubMed] [Google Scholar]
  26. Robinson J. Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood. J Virol. 1975 May;15(5):1065–1072. doi: 10.1128/jvi.15.5.1065-1072.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schabel F. M., Jr The antiviral activity of 9-beta-D-arabinofuranosyladenine (ARA-A). Chemotherapy. 1968;13(6):321–338. doi: 10.1159/000220567. [DOI] [PubMed] [Google Scholar]
  28. Shaw J. E., Seebeck T., Li J. L., Pagano J. S. Epstein-Barr virus DNA synthesized in superinfected Raji cells. Virology. 1977 Apr;77(2):762–771. doi: 10.1016/0042-6822(77)90497-4. [DOI] [PubMed] [Google Scholar]
  29. Sidwell R. W., Dixon G. J., Sellers S. M., Schabel F. M., Jr In vivo antiviral properties of biologically active compounds. II. Studies with influenza and vaccinia viruses. Appl Microbiol. 1968 Feb;16(2):370–392. doi: 10.1128/am.16.2.370-392.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Summers W. C., Klein G. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid. J Virol. 1976 Apr;18(1):151–155. doi: 10.1128/jvi.18.1.151-155.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Symons R. H. Synthesis of (alpha-32P) ribo- and deoxyribonucleoside 5'-triphosphates. Methods Enzymol. 1974;29:102–115. [PubMed] [Google Scholar]
  32. Thorley-Lawson D., Strominger J. L. Transformation of human lymphocytes by Epstein-Barr virus is inhibited by phosphonoacetic acid. Nature. 1976 Sep 23;263(5575):332–334. doi: 10.1038/263332a0. [DOI] [PubMed] [Google Scholar]
  33. Weissbach A., Hong S. C., Aucker J., Muller R. Characterization of herpes simplex virus-induced deoxyribonucleic acid polymerase. J Biol Chem. 1973 Sep 25;248(18):6270–6277. [PubMed] [Google Scholar]
  34. Whitley R. J., Ch'ien L. T., Dolin R., Galasso G. J., Alford C. A., Jr Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med. 1976 May 27;294(22):1193–1199. doi: 10.1056/NEJM197605272942201. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES